Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perinatal SMILES: Ketamine and IPT for Postpartum Depression
NCT06048263Phase 3Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in postpartum depression (PPD), sponsored by Washington University School of Medicine. Planned start Oct 2025; status: withdrawn.
02
Drugs
ketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT06048263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06048263.